Absence of relevant QT interval prolongation in not critically ill COVID-19 patients

SARS-CoV-2 is a rapidly evolving pandemic causing great morbimortality. Medical therapy with hydroxicloroquine, azitromycin and protease inhibitors is being empirically used, with reported data of QTc interval prolongation. Our aim is to assess QT interval behaviour in a not critically ill and not m...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Jáimez, Juan, Macías-Ruiz, Rosa, Bermúdez-Jiménez, Francisco, Rubini-Costa, Ricardo, Ramírez-Taboada, Jessica, Flores, Paula Isabel García, Gallo-Padilla, Laura, García, Juan Diego Mediavilla, García, Concepción Morales, Suárez, Sara Moreno, Molina, Celia Fignani, López, Miguel Álvarez, Tercedor, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722753/
https://www.ncbi.nlm.nih.gov/pubmed/33293554
http://dx.doi.org/10.1038/s41598-020-78360-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722753/
https://www.ncbi.nlm.nih.gov/pubmed/33293554
http://dx.doi.org/10.1038/s41598-020-78360-9

Ejemplares similares